ライフサイエンスコーパス: restrictive lung disease

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 ltrative process, abnormal gas exchange, and restrictive lung disease.

2 in lung development and the pathogenesis of restrictive lung disease.

3 ogram, mitral valve prolapse, arrhythmia, or restrictive lung disease.

4 ath variability was reduced in patients with restrictive lung disease: 27 times for expiratory time,

5 The most common type of major sequela was restrictive lung disease (5.4% [2.5-10.2%]) .

6 In conclusion, patients with restrictive lung disease adopt a tightly constrained bre

7 cant increases in interstitial thickening or restrictive lung disease among this population.

8 veloped severe dyspnea and was found to have restrictive lung disease and evidence of alveolitis.

9 nificant, independent, protective factor for restrictive lung disease and FVC or DLCO values.

10 nobtrusively over 1 hour in 10 patients with restrictive lung disease and in 7 healthy subjects.

11 States and in severe cases can resolve with restrictive lung disease and pleural fibrosis.

12 ive pulmonary disease (COPD), one had severe restrictive lung disease, and one had a coagulopathy; th

13 ant contractures with limited eye movements, restrictive lung disease, and variable absence of crucia

14 in patients with CHD with renal dysfunction, restrictive lung disease, anemia, and cirrhosis.

15 Patients with restrictive lung disease are typically dyspneic and have

16 oracic configuration, in addition to causing restrictive lung disease, can cause respiratory distress

17 ordingly, we hypothesized that patients with restrictive lung disease display decreased variability o

18 ed cognitive ability, poor pulmonary status, restrictive lung disease, history of frequent pneumonias

19 nge of pigmentation and an increased risk of restrictive lung disease in adults.

20 In adults with NMD, restrictive lung disease is in part caused by reduced ch

21 tandard global burden of disease categories (restrictive lung disease, obstructive lung disease, bron

22 ; odds ratio, 2.0; p =.032) and a history of restrictive lung disease (odds ratio, 3.6; p =.044).

23 hic pulmonary fibrosis (IPF), a progressive, restrictive lung disease that is refractory to glucocort

24 22q11.2DS is associated with restrictive lung disease, worse aerobic capacity, and in

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。